Taro Ikegami
Head And Neck Surgery, 1076 Kiyuna
Ginowan, 9012720, Japan
Ginowan, 9012720, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Nutritional and Inflammatory Markers Associated with Complete Response to Near-Infrared Photoimmunotherapy in Recurrent Head and Neck Squamous Cell Carcinoma.
Journal: Cancers
Published: February 26, 2026
RPS26 Expression as a Predictive Biomarker and Functional Modulator in Sublingual Immunotherapy for Japanese Cedar Pollinosis.
Journal: International archives of allergy and immunology
Published: January 11, 2026
Clinical, virological, and immunohistochemical features of laryngeal papilloma with low-risk human papillomavirus infection: insights from a 13-year institutional cohort.
Journal: World journal of surgical oncology
Published: September 30, 2025
Preliminary observations on peripheral inflammatory markers in NIR-PIT and ICI-treated recurrent head and neck squamous cell carcinoma.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: September 26, 2025
Development of a novel prognostic assessment tool for recurrent respiratory papillomatosis.
Journal: BMC medicine
Published: August 19, 2025
Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer.
Journal: Anticancer research
Published: June 10, 2024
Prospective Analysis of Squamous Cell Carcinoma Antigen-1 and -2 for Diagnosing Sinonasal Inverted Papilloma.
Journal: Journal of clinical medicine
Published: March 28, 2024
p16 Overexpression in Sinonasal Squamous Cell Carcinoma: Association with Human Papillomavirus and Prediction of Survival Outcomes.
Journal: Journal of clinical medicine
Published: September 28, 2023
Biomarkers for Predicting Anti-Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: April 25, 2023
Exploring stage‑specific embryonic antigen 3 involvement in oral cancer progression and as a potential target for taxane‑based chemotherapy.
Journal: Oncology reports
Published: April 07, 2023
Human Papillomavirus Infection and EGFR Exon 20 Insertions in Sinonasal Inverted Papilloma and Squamous Cell Carcinoma.
Journal: Journal of personalized medicine
Published: March 28, 2023
Last Updated: 09/26/2026